In the human setting, GA treatment of fibroblast-like synoviocytes isolated from patients with rheumatoid arthritis increases the levels of pro-apoptotic caspase-3 and decreases the expression of pro-inflammatory molecules in vitro [50]. The gene discussed is CASP3; the disease is rheumatoid arthritis.